Patient Dosimetry During Interventional Cardiology Procedures

Interventional cardiology procedures generally require prolonged fluoroscopy time and a series of radiographic exposures which result in increased radiation doses and risks to patient and personnel. In order to assess patients' stochastic risk during PTCA, the dose-area product (DAP) was measur...

Full description

Saved in:
Bibliographic Details
Published in:Radiation protection dosimetry 1998-01, Vol.80 (1-3), p.151-153
Main Authors: Neofotistou, V., Karoussou, A., Lobotesi, H., Hourdakis, K.
Format: Article
Language:English
Subjects:
Biological and medical sciences
Medical sciences
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Interventional cardiology procedures generally require prolonged fluoroscopy time and a series of radiographic exposures which result in increased radiation doses and risks to patient and personnel. In order to assess patients' stochastic risk during PTCA, the dose-area product (DAP) was measured and the effective dose was calculated by multiplying the DAP by a factor of 0.2 mSv.Gy-1.cm-2. The risk for deterministic effects was estimated by the skin entrance exposure (SEE) measured either by TLDs placed on the patients's skin or calculated using the DAP value over the mean field size. Finally, the clinical protocols used by two teams of cardiologists during RF catheter ablation were compared and the differences in effective doses delivered to the patient were discussed. Complying with the European Directive on Patient Protection, reference dose levels were tentatively suggested in terms of DAP.
ISSN:0144-8420
1742-3406
DOI:10.1093/oxfordjournals.rpd.a032493